Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Odyssey Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '23 Dec '22
Net Income
-130.92-124.67
Depreciation & Amortization
4.912.76
Share-Based Compensation
6.265.52
Other Operating Activities
2.0416.54
Operating Cash Flow
-112.73-99.84
Capital Expenditures
-5.06-13.03
Change in Investments
-159.99-
Other Investing Activities
0.02-
Investing Cash Flow
-165.02-13.03
Share Issuance / Repurchase
96.84177.84
Debt Issued / Paid
-4.764.88
Financing Cash Flow
92.08182.72
Net Cash Flow
-185.6769.83
Free Cash Flow
-117.78-112.87
Free Cash Flow Margin
-11358.15%-
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).